行情

AMPE

AMPE

安皮奥制药
AMEX
0.3450
-0.0301
-8.02%
盘后: 0.3220 -0.023 -6.67% 17:47 12/02 EST
开盘
0.3843
昨收
0.3751
最高
0.3846
最低
0.3015
成交量
22.88万
成交额
0
52周最高
16.80
52周最低
0.1990
市值
520.46万
市盈率(TTM)
-0.2479
分时
5日
1月
3月
1年
5年
Ampio Pharmaceuticals 延长首席执行官 Michael Martino 的任期;分享
Ampio Pharmaceuticals 延长首席执行官 Michael Martino 的任期;分享
MT Newswires · 09/02 10:15
AMPE 简况
Ampio Pharmaceuticals, Inc. is a biopharmaceutical company that is focused on the research, development, and advancement of immunomodulatory therapies for the treatment of pain from osteoarthritis. The Company's lead product candidate, Ampion has immunomodulatory action and anti-inflammatory effects, which provide a treatment for individuals with inflammatory conditions including, but not limited to, severe osteoarthritis of the knee (OAK); osteoarthritis related to other joints, such as hip, shoulder, ankle and hand; and the widespread inflammation associated with COVID-19 infection. Ampion is in development as an intra-articular injection treatment for severe OAK, an intravenous (IV) and inhaled treatment for hospitalized severe and/or critical COVID-19 patients, and an at-home inhalation treatment for patients with prolonged respiratory symptoms due to COVID-19, referred to as Long-COVID. Its clinical studies include AP-013, AP-017, AP-019 and AP-018.

微牛提供Ampio Pharmaceuticals Inc(AMEX-AMPE)的股票价格、实时市场报价、专业分析师评级、深度图表和免费的AMPE股票新闻,以帮助您做出投资决策。

模拟交易:模拟炒股免费实操交易技能。您可用虚拟资金在真实市场环境中零成本、零风险体验交易AMPE股票基本功能。